According to a recent LinkedIn post from Carta Healthcare, physician use of artificial intelligence in clinical practice appears to be growing rapidly based on data cited from an American Medical Association survey. The post indicates that four out of five physicians now use AI, with usage reportedly doubling since 2023 and concentrated in tasks such as clinical documentation and research summaries.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post also notes that most surveyed physicians expect AI to improve work efficiency, diagnostic ability, and cognitive load, and that a growing majority view AI as providing an advantage in patient care. At the same time, the content points to persistent concerns around patient privacy, potential skill erosion, and the desire of physicians to retain influence over how AI tools are implemented.
For investors, the described trends suggest accelerating adoption of AI-enabled workflows across healthcare, which could expand the addressable market for clinical data and decision-support providers such as Carta Healthcare. Emphasis on clinician oversight and privacy risk may favor vendors that can demonstrate robust compliance, explainability, and co-pilot style tools rather than fully autonomous systems.
If Carta Healthcare’s products align with documentation, summarization, or workflow-efficiency use cases highlighted in the survey, rising utilization could support demand growth and longer-term recurring revenue opportunities. However, the concerns referenced in the post also imply that regulatory developments, liability frameworks, and provider governance over AI deployment may influence adoption speed and pricing power across the sector.